"Le CH de Saint-Brieuc dispense des soins spécialisés pour l'ensemble du département des Cotes d'Armor. Il est, par sa capacité, son activité et son plateau technique, le 3ème établissement public de santé breton, après les CHU de Rennes et Brest. Il assume les fonctions d’hôpital de proximité pour une population d’environ 100 000 habitants. Il dispose de 1247 lits et places répartis sur l'hôpital Yves le Foll (667 lits et 96 places MCO-SSR) et le Centre gériatrique des Capucins (472 lits et 12 places). Le CH de Saint-Brieuc est également l'établissement support du Groupement Hospitalier du Territoire d'Armor lequel regroupe les hôpitaux de Guingamp, Lannion-Trestel, Paimpol, Tréguier, Saint-Brieuc et Penthièvre et Poudouvre (CH2P)."

During the past decade, Hopital Yves Le Foll; Hematologie Oncologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Yves Le Foll; Hematologie Oncologie" are "Colorectal Cancer" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Hopital Yves Le Foll; Hematologie Oncologie" in a lesser frequency.

Most popular intervention types in "Hopital Yves Le Foll; Hematologie Oncologie" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "CHOP" (1 trials) and "rituximab [MabThera/Rituxan]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Yves Le Foll; Hematologie Oncologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Yves Le Foll; Hematologie Oncologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hopital Yves Le Foll; Hematologie Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Yves Le Foll; Hematologie Oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".